BioNTech SE

Realamh

In short, they most likely bounce from this level for a short time, but whether they continue their bull run or not depends on price action in the next couple weeks. I have some remarks on the charts that might help following up with their moves. The RSI for all three companies are in oversold area and historically we have seen them move back up when they hit 30...

Hiddenharmonicstrading

2 day Candles here, I will be looking to enter early if i see a volume signature in Tc2k in low tf, i will update as well Huge growth here //Covid Profits #'s below in Koyfin app.koyfin.com

MuffyPuffy

After the last ATH, Biontech corrected quite swiftly with up to -31% on the swing low. Let's analyze where we are going most likely to trend next: First look at the bigger scope: Lower time frame: Wave...

rbswingtrader

Well, i expected a deeper correction but the news flowing around are too good for both BNTX and MRNA and it hasn't taken a deep dive i expected. In fact, i see BNTX doing another run up now with the start of this Wave. I will post the MRNA chart as well. PS. i did loose some money on MRNA shorts in the last few weeks. Planning to go long soon again on these.

yrmstocks

212 day above 269.42 week 2up already triggered also sitting at a historical level of support/res

aox8zs

Come on now, get on the stocks, the bulls, the rodeo begins....

aox8zs

Strong Long 500 Zig Zag Target Reached Take. BUY it very fast ... 21000

ozwald

bottom fishing play looking for a bounce to fill those gaps to 270 and 305

sinakeshawarz

I am Bullish on BNTX. Put it in your watchlist. BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.

SAM_46

| BNTX | SHORT @ 340 - 336 | TP @ 332, 328, 324, 320, 316 | SL @ 356 | PATTERN = N/A | PNF chart on the hourly shows a trend reversal. The strategies I use involve a mix of PNF and Renko. My type of trading is strictly swing trading.

huntersanna33

MA have caught up in this name which offers a good entry point that is not overextended. Stock has made 2 100% run ups after a consolidation pattern. If we look at volume in the last run up there was more volume than the previous run which indicates inst. support. Will manage risk at the lows of Thursday which is about a 3.7% risk where the upside potential is the...

shkspr

NASDAQ:BNTX Possible Scenario: LONG Evidence: Price Action, TP1: 360$ TP2: 377$ Call options, strike 360$, 11/19/2021. Call options, strike 365$, 09/17/2021. *This is my idea and could be wrong 100%.

hadimozayan

SNIPER STRATEGY This magical strategy works like a clock on almost any charts Although I have to say it can’t predict pullbacks, so I do not suggest this strategy for leverage trading. It will not give you the whole wave like any other strategy out there but it will give you huge part of the wave. The best timeframe for this strategy is Daily, Weekly and Monthly...

Ocamond

NASDAQ:BNTX Hey guys, This is my first analysis so please do not be too harsh on me. After several months of exceptional performance, I do believe that the Biontech stock reached its peak on 10-08-2021 (450$). The vaccinations are still going on and a lot of people opt for the Fizer/Biontech vaccine with certainly has its impact on the stock market. I have...

kislayraj995

I am anticipating a new ATH very soon as you can see it is consolidating for a longer run.

IM-Forex

#BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Covid-19 vaccine maker BioNTech plans to make any malaria or tuberculosis vaccine it develops in Africa, the company said on Friday. The announcement comes at a time when debate is...

WaverVanir

.382 retrace with a gap fill. It could break out or go one more leg down. I like the double bottom as well... it's.... good enough ..

Rocky88888888888

$BNTX Leaps Calls 680 Mar 17th 2023 Returns +403% The FDA approval of Pfizer’s COVID-19 vaccine is a ‘critical step forward in vaccine confidence’: Doctor